All NSAIDs variably inhibit COX-1 and COX-2 and the mechanisms of inhibition fall into three broad categories, although there are exceptions. For example, nimesulide is a weak competitive inhibitor of ...
Cyclooxygenases (COX-1 and COX-2) lie at the heart of the inflammatory cascade, catalysing the conversion of arachidonic acid into bioactive prostaglandins that mediate pain, fever and vascular ...
COX-2-selective nonsteroidal anti-inflammatory drugs (NSAIDs) appear to be a safer option than their nonselective counterparts among patients with atrial fibrillation (AF) who are taking a direct oral ...
A startling new preprint research paper posted to the medRxiv* server warns against the use of commonly used non-steroidal anti-inflammatory drugs (NSAIDs) belonging to the category of cyclooxygenase ...
BAE: Bovine aortic endothelial; RHP: Recombinant human protein. NSAIDs variably inhibit prostaglandin H synthase (COX). COX-2 was cloned in 1991, and it was subsequently established that COX-1 does ...